Navigation Links
uniQure Initiates Phase I in Acute Intermittent Porphyria
Date:12/11/2012

AMSTERDAM, December 11, 2012 /PRNewswire/ --

uniQure B.V., a leader in the field of human gene therapy, today announced the start of its Phase I clinical trial in acute intermittent porphyria (AIP) with the treatment of the first patient. The study is conducted under the aegis of the AIPGENE consortium, a pan-European collaboration funded in part by the European Commission's Seventh Framework Program with the aim to develop a gene therapy for the treatment of AIP, a rare and devastating disease caused by mutations in the porphobilinogen deaminase gene (PBGD). AIP can be life-threatening and the long-term effects include irreversible nerve damage, liver cancer and kidney failure. uniQure was granted orphan drug designation for the treatment of AIP in 2009 from the European Medicines Agency.

"The start of the AIP Phase I study marks the first of four programs that will enter clinical trials over the next 12 months," says Jörn Aldag, CEO of uniQure.  "After AIP we expect clinical trials to be initiated in Parkinson's disease, hemophilia B, and Sanfilippo B. After many years of building and developing our capabilities and competencies, and the approval in November of Glybera for LPLD as the first gene therapy in the Western world, we are highly motivated to expedite the clinical development of our other advanced gene therapies."

About the AIP Phase I study

The Phase I will enroll eight patients with severe AIP at two centers: the Clinical University of Navarra, Pamplona, Spain, and the 12 de Octubre University Hospital,, Madrid, Spain. The study's primary objective is the assessment of safety and determination of the maximum tolerated dose.  Secondary objectives include tolerability of treatment, pharmacokinetics, changes in the levels of surrogate markers of activity including porphobilinogen (PBG) and delta-aminolevulinic acid (ALA), and assessment of symptom control, neuro-psychological changes and quality of life. All pa
'/>"/>

SOURCE uniQure B.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. uniQure Appoints Hans Christian Rohde Chief Commercial Officer
2. uniQure Licenses RNA Interference Technology to Advance Huntingtons Disease Program
3. Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies
4. The Acute Liver Failure Study Group Initiates Phase 2a Study of OCR-002 for Treatment of Acute Liver Failure after Acetaminophen Overdose
5. Isis Pharmaceuticals Initiates Phase 1b/2a Study Of ISIS-SMNRx In Patients With Spinal Muscular Atrophy
6. Isis Initiates Phase 2 Study Of ISIS-FXIRX In Patients Undergoing Knee Replacement Surgery
7. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
8. Healthpoint Biotherapeutics Initiates Phase III Study of Unique Investigational Cell-Based Therapy for Venous Leg Ulcers
9. New Jersey Health Foundation Initiates Program To Spur Innovative Research
10. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
11. ImmusanT Initiates Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 In response to ... Association of Sierra Leone , Direct Relief ... for the treatment of local health workers who ... a new dedicated Ebola care center was constructed for foreign ... facility is not available for local Sierra Leonean health workers. ...
(Date:12/22/2014)... NxStage Medical, Inc. (NASDAQ: NXTM ... announced today that the U.S. Food and Drug ... perform hemodialysis overnight while the patient is at ... System One is the first and only hemodialysis ... Home nocturnal hemodialysis is an ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2
... BETHESDA, Md., July 05, 2007 /PRNewswire-FirstCall/ -- Micromet,Inc. ... of,novel, proprietary antibody-based products for cancer, inflammatory,and autoimmune ... Chief Executive Officer of Micromet, Inc., will,present at ... in New York on Thursday, July 12, 2007 ...
... WIRE)--Jul 2, 2007 - Tercica, Inc.,(NASDAQ:TRCA) today announced ... at the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference ... Wednesday, July 11, 2007 at 4:00 p.m. Eastern,time ... and slide presentation will be available,via the Internet ...
Cached Medicine Technology:Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin,Emerging Growth Conference 2
(Date:12/26/2014)... 26, 2014 It is said that nothing ... Today, UWDress.com, the famous wedding dress supplier, shows its ... site-wide cocktail gown promotion. , UWDress.com’s navy cocktail gowns ... they come in high fashion styles. Simple dresses in bright ... the occasion; they are specially designed for those who want ...
(Date:12/26/2014)... 26, 2014 Plugin and template developers from ... 5 Plugin for Final Cut Pro X. , “TransPack Volume ... tool to pull off an industry professional look” Said Christina ... hands on TransPack Volume 5, a new level of professionalism ... set of over 50 Final Cut Pro X transitions featuring ...
(Date:12/26/2014)... 2014 DW-InductionHeating.com (DaWei Induction Heating Co.) ... and developing, producing and marketing of a series of ... announces their new series of induction brazing equipments ... company, induction brazing refers to the joining ... material and heat. The manager says that there are ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
Breaking Medicine News(10 mins):Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2
... The Food and Drug Administration has cleared a new diagnostic ... thousands of AIDS patients stricken with cryptococcosis, a fungal meningitis. ... professor of microbiology of the University of Nevada School of ... of Oklahoma. The new, rapid blood test known as ...
... -- Obesity is costing states up to $15 billion each ... already accounts for 10 percent or more of the state,s ... University and the U.S. Agency for Healthcare Research and Quality. ... large part of the bill, with the state,s share of ...
... (HealthDay News) -- Chicks and ducklings from a mail-order hatchery ... United States, the U.S. Centers for Disease Control and Prevention ... 65 people in 20 states and Salmonella Johannesburg ... 54 of the people infected with the Altona strain found ...
... , New York, NY, August 24, 2011 Nearly three-quarters (72%) ... their jobs over the last two years said that they ... because of cost, according to a new Commonwealth Fund ... or medical debt, compared to about half (49%) who lost ...
... WEDNESDAY, Aug. 24 (HealthDay News) -- Exclusive breast-feeding of ... them against developing the itchy skin disorder known as ... breast-feeding, an infant receives only breast milk, with no ... Organization. Exclusive breast-feeding up to 6 months of age ...
... as well as others in Canada and the United ... major motion pictures that depict smoking -- leading to ... of California, San Francisco (UCSF) researcher has found. ... , those subsidies, along with government inaction on stricter ...
Cached Medicine News:Health News:FDA clears new IMMY and University of Nevada, Reno life-saving blood test 2Health News:Obesity Costing States Billion in Yearly Medical Expenses 2Health News:Three-quarters of those who have lost jobs and health insurance are skipping needed health care 2Health News:Three-quarters of those who have lost jobs and health insurance are skipping needed health care 3Health News:Three-quarters of those who have lost jobs and health insurance are skipping needed health care 4Health News:Breast-Feeding Won't Prevent Kids' Eczema, Researchers Say 2Health News:Taxpayer film subsidies promote youth smoking 2
Patented* Design for Endoscopic Shunt Placement. Designed to pass through standard shunt ventricular catheters for optically guided placement....
Preclude Dura Substitute is the only non-biological membrane designed to "seal" around suture holes. 0.3 mm as nominal thickness....
... Lyoplant is a new ... pericardium. A pure collagen implant, ... to three months, replacing implant ... collagen. Its natural structure minimizes ...
The Bovie IDS Series are the latest electrosurgical generators with fully digital implementation....
Medicine Products: